6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Walgoolan Project Update Grant of Tenement
13m ago	Suzano Sells 12.7 Million Tonnes of Pulp for the First Time in Its History
14m ago	CHAMPION IRON REPORTS ITS FY2026 FOURTH QUARTER PRODUCTION AND SALES
15m ago	NovaRed Mining Completes Plume Tenure Registration; 2,063-Hectare Alteration Target Now Fully Secured for 2026 Geophysical Program
15m ago	Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)

About

Iovance Biotherapeutics Inc (NASDAQ:IOVA) — investor relations, events, news, and company updates on 6ix.

Latest News

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

Financials

Revenue

$263.5 M

Market Cap

$1.41 B

EPS

-1.09

Community Chat

Ask AI